Cathie Wood's ARK Invest Sells Over 840,000 Shares of Seres Therapeutics

Investing

Published: August 31, 2021 8:35 am

One of the ARK Invest exchange-traded funds run by ETF star Cathie Wood sold over 840,000 shares of Seres Therapeutics Inc. (NASDAQ: MCRB) shares on Monday, as the price of this ETF was up nearly 1% in Monday’s session. The fund is up significantly in the past year.

ARK Innovation ETF (NYSEARCA: ARKK) sold 846,468 shares of Seres Therapeutics. At Monday’s closing price, this would have valued this sale at roughly $5.2 million. This is only a small fraction of the total holdings. This ETF is up 35% over the past 52 weeks.

Here are all the ARK Invest sales on Monday:

Fund	Ticker	Name	Shares
ARKF	6060HK	ZHONGAN ONLINE P&C INSURANCE	981,100
ARKF	9923HK	YEAHKA	297,200
ARKG	PSTI	PLURISTEM THERAPEUTICS	10,518
ARKG	CLLS	CELLECTIS	7,300
ARKG	RHHBY	ROCHE	78,900
ARKK	MCRB	SERES THERAPEUTICS	846,468
ARKK	IOVA	IOVANCE BIOTHERAPEUTICS	71,749
ARKQ	ISRG	INTUITIVE SURGICAL	1,700
ARKQ	NXPI	NXP SEMICONDUCTORS	13,000
ARKQ	BABA	ALIBABA	15,089
ARKQ	GOOG	ALPHABET	4,808
ARKW	MELI	MERCADOLIBRE	4,500
ARKW	SE	SEA	34,049

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.

ALSO READ: Fast Money Hedge Funds Are Buying These 5 Red-Hot Stocks Now

Travel Cards Are Getting Too Good To Ignore

Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.

We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.

It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.

We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.